Members of our WCS Scientific Advisory Board are recognized experts in their specialty areas, which include assessment and cognitive remediation of neuropsychiatric disorders and vocational rehabilitation.

Jeffrey T. Barth, Ph.D., ABPP
Dr. Barth is a board-certified clinical neuropsychologist. At the University of Virginia School of Medicine, he is chief of medical psychology and John Edward Fowler Professor of Clinical Psychology in the Department of Psychiatric Medicine, director of the Neuropsychology Assessment Laboratories, and a professor at the Institute of Law, Psychiatry and Public Policy. The author of more than 100 scientific articles, Dr. Barth has served as an investigator or consultant to numerous research grants funded by organizations such as the National Institutes of Health, the Robert Wood Johnson Foundation, and the Pew Foundation, among others. Interests include closed head injury, degenerative neurologic disease, cerebrovascular disorders, neoplasms, infections, substance abuse, and epilepsy.

Michael Katch, Ph.D., CSW
Dr. Katch administers behavioral health services as the Regional Assistant Vice President of FEGS, a non-profit health and human service organization. He is an adjunct associate professor at the Columbia University School of Social Work and an assistant clinical professor at the Mount Sinai School of Medicine, Department of Community Medicine, where he precepts fourth-year medical students on research methodology. He also serves as a consultant for organizations with HIV/AIDS programs and for organizations undergoing managed care transitions. Dr. Katch belongs to several professional organizations, including the National Association of Social Workers, the Academy of Certified Social Workers, and the New York State AIDS Lay Health Services Association, and has authored a number of journal articles on issues in social work.

Alice Medalia, Ph.D.
Dr. Medalia is an associate professor of clinical neurology, psychiatry, and behavioral sciences at the Albert Einstein College of Medicine and the director of neuropsychology for the Department of Psychiatry and Behavioral Sciences at Montefiore Medical Center in New York City. The author of more than 50 publications, she has consulted worldwide to agencies interested in providing cognitive remediation services to behavioral health/mentally ill populations. She has participated in the editorial review process of a dozen professional journals and served as a consultant to numerous research grants. Dr. Medalia frequently lectures on her research on evidence-based treatment and treatment outcomes of cognitive impairment in psychiatric populations.

Bruce Phariss, M.D.
Dr. Phariss is a Diplomate of the American Board of Psychiatry and Neurology and holds subspecialty certification in addiction psychiatry. He is clinical instructor of psychiatry and public health at the Weill Medical College of Cornell University and serves as medical director for two state-licensed intensive outpatient substance abuse treatment facilities: The Midtown Center for Treatment and Research, Weill Medical College of Cornell University, and Exponents Treatment Exchange. Dr. Phariss maintains a private psychiatric practice in New York City. He teaches medical students and residents and has lectured extensively to professional groups about addiction.

Wilfred G. van Gorp, Ph.D., ABPP
Dr. van Gorp is a board-certified clinical neuropsychologist. At the Weill Medical College of Cornell University, he is director of the Neuropsychology Assessment Program and professor of psychology in psychiatry. He is also an associate attending psychologist at Memorial Sloan Kettering Cancer Center and New York Hospital and is on the faculty of New York Medical College. As the principal investigator of numerous National Institute of Mental Health and other grants, he has focused his research on the neuropsychology of HIV/AIDS and geriatric mood disorders. Dr. van Gorp has published more than 100 scientific articles, is editor of the Journal of Clinical and Experimental Neuropsychology, and serves on the editorial board or as a reviewer for 25 other journals.

David M. Erlanger, Ph.D.
Dr. Erlanger received his doctorate in psychology from Columbia University and completed training in clinical neuropsychology at the Albert Einstein College of Medicine and the Weill Medical College of Cornell University. He is on the faculties of the Albert Einstein College of Medicine/Montefiore Hospital and Columbia University/Teachers College and serves as a consultant in research methods and assessment to the New York State Psychiatric Institute of Columbia-Presbyterian Medical Center.

Daniel J. Feldman, Ph.D.
Dr. Feldman completed training in neuropsychology at the Weill Medical College of Cornell University, focusing his research on the neuropsychiatric sequelae of HIV-infection. Clinically, he works primarily doing neuropsychological assessment of adults in outpatient and medical-legal settings. He has published and continues to study in the areas of neuropsychology, personality research, psychometrics, and advanced statistical techniques for the behavioral sciences.